RecruitingNot ApplicableNCT03750981

C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)

Does High-Intensity Functional Training Improve Patient Movement and Quality of Life? A Study of CrossFit® in Cancer Survivors


Sponsor

Barbara Ann Karmanos Cancer Institute

Enrollment

500 participants

Start Date

Nov 12, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

This study will introduce cancer survivors to cross-training with the expectation that the program proposed will ultimately result in superior improvements in functional performance, body composition and quality of life compared with the current American Cancer Society (ACS) guidelines for cancer survivors.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Aged 18 years or older at time of program recruitment
  • Diagnosed with any cancer
  • Cleared from their physician to participate in the program (We assume that most patients will have completed treatment, however if a patient is currently under treatment, this should be their oncologist. If the patient is not currently undergoing treatment, this could be primary care physician or oncologist).
  • Available transportation to and from the facility on session days

Exclusion Criteria2

  • Widely metastatic cancers to the brain or bone may be excluded.
  • Patients using mobility assistance devices may be excluded. Exclusionary criteria will be reviewed on a case-by-case basis and patients with these limitations may be included with approval from Dr. Beebe-Dimmer and the referring physician.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORAL12 week pilot intervention study.

Participants will begin a 12-week high-intensity functional training program conducted at CrossFit® in the D, located in downtown Detroit, Northville Athletix in Northville and Five Lakes CrossFit® in Farmington Hills.


Locations(1)

Barbara Ann Karmanos Cancer Institute

Detroit, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03750981


Related Trials